Renk Group AG enters a decisive period this week, with investor confidence hanging on the resolution of two persistent issues: disappointing cash generation and blocked defense exports. The German defense supplier’s stock, trading around €54.66, has recovered 17% from its March low of €46.64 but remains nearly 40% below its 52-week high of €88.73. This disconnect between a record order book and market valuation sets the stage for critical investor meetings.
On Wednesday, April 22, management will host a pre-close call in Augsburg, offering a preliminary look at first-quarter performance. This is followed by a capital markets conference in Munich the next day. These events are seen as a crucial litmus test before the detailed quarterly report on May 6.
The company’s 2025 results presented a mixed picture. Revenue climbed to €1.37 billion, while adjusted EBIT jumped approximately 22% to €230 million. Net profit nearly doubled to €101 million, prompting a 38% dividend increase. However, these strong figures were overshadowed by a weak free cash flow of just €67 million, which fell well short of the company’s own 80% cash conversion target. Delayed customer payments and increased working capital were the primary culprits, compounded by the shift of roughly €200 million in revenue volume from 2025 into the first half of 2026.
A significant geopolitical overhang adds to the operational challenges. The German government’s suspension of certain arms exports to Israel has put an estimated €80 to €100 million in revenue for 2026 at risk. These exports relate to gear systems for Israeli armored vehicles. In response, Renk is shifting the affected production line to its existing facility in Muskegon, Michigan. This strategic pivot to the U.S., supported by a $150 million investment through 2030, will allow future orders to be processed via the U.S. Foreign Military Sales program, bypassing German export restrictions.
Should investors sell immediately? Or is it worth buying Renk?
This complex backdrop has triggered a tug-of-war among institutional investors. Hedge funds AQR Capital Management and Marshall Wace have recently expanded their short positions, betting on further operational setbacks. On the opposing side, Wellington Management increased its stake to over 5% using structured financial instruments. In a notable move, CFO Anja Mänz-Siebje also purchased shares personally earlier this year, a signal market observers interpret as a vote of confidence directed at the skeptics.
For the current year, management has set ambitious targets, forecasting revenue above €1.5 billion. Adjusted EBIT is projected to land between €255 million and €285 million, with CEO Susanne Wiegand aiming for the upper half of that range. The achievability of these goals hinges on whether the previously delayed contracts are now being recognized as planned revenue. The pre-close call will provide the first indications on this front.
The stock’s technical picture reflects the prevailing uncertainty. The share price has oscillated around the flat line year-to-date and trades well below its 200-day moving average of approximately €61. All eyes are now on this week’s communications for clues on a potential turnaround, with the annual general meeting scheduled for June 10 to vote on the proposed dividend increase.
Ad
Renk Stock: Buy or Sell?! New Renk Analysis from April 20 delivers the answer:
The latest Renk figures speak for themselves: Urgent action needed for Renk investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 20.
Renk: Buy or sell? Read more here...
